Pharmacogenetics of asthma in children

Allergy, Asthma and Immunology Research

Volumn 2, Issue 1, 2010, Pages 14-19

  Kondo, Naomi ^a   Matsui, Eiko ^a   Nishimura, Akane ^a   Kaneko, Hideo ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Asthma; Individualized medicine; Pharmacogenetics

Indexed keywords

ADAM PROTEIN; ADAM33 PROTEIN; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID DERIVATIVE; CYTOKINE; GAMMA INTERFERON RECEPTOR 1; IMMUNOGLOBULIN E; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 4 RECEPTOR ALPHA; LEUKOTRIENE C4 SYNTHASE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; NEURONAL NITRIC OXIDE SYNTHASE; PRANLUKAST; SUPLATAST TOSYLATE; UNCLASSIFIED DRUG; ZAFIRLUKAST;

AMINO ACID SUBSTITUTION; ASTHMA; ATOPY; CHILD; CHILDHOOD DISEASE; DISEASE CLASSIFICATION; DRUG MECHANISM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HLA SYSTEM; HUMAN; IMMUNOGLOBULIN PRODUCTION; PHARMACOGENETICS; PRACTICE GUIDELINE; REVIEW; SIGNAL TRANSDUCTION; TARGET ORGAN; UNSPECIFIED SIDE EFFECT;

EID: 77952777740     PISSN: 20927355     EISSN: 20927363     Source Type: Journal    
DOI: 10.4168/aair.2010.2.1.14     Document Type: Review

References (34)

1. Global Initiative for Asthma (GINA): Global Strategy for Asthma Management and Prevention. 2006. Available from: http://www.ginasthma.org
2. Ober C, Hoffjan S. Asthma genetics 2006: the long and winding road to gene discovery. Genes and Immunity 2006;7:95-100.
3. Juhn YJ, Kita H, Lee LA, Smith RW, Bagniewski SM, Weaver AL, Pankratz VS, Jocobson RM, Poland GA. Childhood asthma and human leukocyte antigen type. Tissue Antigens 2007;69:38-46. (Pubitemid 46025337)
4. Juhn YJ, Kita H, Bagniewski SM, Weaver AL, Pankratz VS, Jocobson RM, Poland GA. Severity of childhood asthma and human leukocyte antigens type. J Asthma 2007;44:163-168 (Pubitemid 46620912)
5. Kondo N, Matsui E, Kaneko H, Fukao T, Teramoto T, Kato Z, Onishi H, Nishimura A. Genetics of pediatric asthma. In: Pawankar R, Holgate ST, Rosenwasser LJ, editors. Allergy frontiers volume 1 allergy frontiers: epigenetics, allergens and risk factors. Heidelberg: Springer; 2009. 189-203.
6. Cookson WO, Sharp PA, Faux JA, Hopkin JM. Linkage between immunoglobulin E responses underlying asthma and rhinitis and chromosome 11q. Lancet 1989;1:1292-1295
7. Shirakawa T, Li A, Dubowitz M, Dekker JW, Shaw AE, Faux JA, Ra C, Cookson WO, Hopkin JM. Association between atopy and variants of the beta subunit of the high-affinity immunoglobulin E receptor. Nat Genet 1994;7:125-130 (Pubitemid 24174648)
8. Mitsuyasu H, Izuhara K, Mao XQ, Gao PS, Arinobu Y, Enomoto T, Kawai M, Sasaki S, Dake Y, Hamasaki N, Shirakawa T, Hopkin JM. Ile50Val variant of IL4R alpha upregulates IgE synthesis and associates with atopic asthma. Nat Genet 1998;19:119-120
9. Shirakawa T, Deichmann KA, Izuhara I, Mao I, Adra CN, Hopkin JM. Atopy and asthma: genetic variants of IL-4 and IL-13 signalling. Immunol Today 2000;21:60-64 (Pubitemid 30069614)
10. Matsui E, Kaneko H, Fukao T, Teramoto T, Inoue R, Watanabe M, Kasahara K, Kondo N. Mutations of the IL-12 receptor b2 chain gene in atopic subjects. Biochem Biophy Res Commun 1999;266: 551-555 (Pubitemid 30028704)
11. Watanabe M, Kaneko H, Shikano H, Aoki M, Sakaguchi H, Matsui E, Inoue R, Kato Z, Kasahara K, Fukutomi O, Kondo T, Kondo N. Predominant expression of 950delCAG of IL-18R alpha chain cDNA is associated with reduced IFN-gamma production and high serum IgE levels in atopic Japanese children. J Allergy Clin Immunol 2002;109:669-675 (Pubitemid 34327195)
12. Aoki M, Matsui E, Kaneko H, Inoue R, Fukao T, Watanabe M, Teramoto T, Kato Z, Suzuki K, Suzuki Y, Kasahara K, Kondo N. A novel single-nucleotide substitution, Leu 467 Pro, in the interferon-gamma receptor 1 gene associated with allergic diseases. Int J Mol Med 2003;12:185-191
13. Henderson WR Jr. The role of leukotrienes in inflammation. Ann Intern Med 1994;121:684-697
14. Sanak M, Hu S, Szczeklik A. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet 1997; 29:1599-1600 (Pubitemid 28036609)
15. Kim SH, Hur GY, Choi JH, Park HS. Pharmacogenetics of aspirinintolerant asthma. Pharmacogenomics 2008;9:85-91.
16. Van Sambeek R, Stevenson DD, Baldasaro M, Lam BK, Zhao J, Yoshida S, Yandora C, Drazen JM, Penrose JF. 5'flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States. J Allergy Clin Immunol 2000;106:72-76 (Pubitemid 30482855)
17. Yoshikawa K, Matsui E, Kaneko H, Fukao T, Inoue R, Teramoto T, Shinoda S, Fukutomi O, Aoki M, Kasahara K, Kondo N. A novel single- nucleotide substitution, Glu 4 Lys, in the leukotriene C4 synthase gene associated with allergic diseases. Int J Mol Med 2005; 16:827-831
18. Gao PS, Kawada H, Kasamatsu T, Mao XQ, Roberts MH, Miyamoto Y, Yoshimura M, Saitoh Y, Yasue H, Nakao K, Adra CN, Kun JF, Moro-oka S, Inoko H, Ho LP, Shirakawa T, Hopkin JM. Variants of NOS1, NOS2, and NOS3 genes in asthmatics. Biochem Biophys Res Commun 2000;267:761-763
19. Reihsaus EM, Innis M, MacIntyre N, Liggett SB. Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 1993;8:334-339
20. Turki J, Pak J, Green SA, Martin RJ, Liggett SB. Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype. J Clin Invest 1995;95:1635-1641
21. Van Eerdewegh P, Little RD, Dupuis J, Mastro RGD, Falls K, Simon J, Torrey D, Pandit S, McKenny J, Braunschweiger K, Walsh A, Liu Z, Hayward B, Folz C, Manning SP, Bawa A, Saracino L, Thackston M, Benchekroun Y, Capparell N, Wang M, Adair R, Feng Y, Dubois J, FitzGerald MG, Huang H, Gibson R, Allen KM, Pedan A, Danzig MR, Umland SP, Egan RW, Cuss FM, Rorke S, Clough JB, Holloway JW, Holgate ST and Keith TP. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 2002;418: 426-430 (Pubitemid 34826843)
22. Kondo N, Matsui E, Kaneko H, Kato Z, Fukao T, Teramoto T, Shikano H, Aoki M, Onishi H, Tatebayashi K, Omoya K, Kondo M, Matsukuma E, Kasahara K, Morimoto N. Genetic defects in downregulation of IgE production and a new genetic classification of atopy. Allergology International 2004;53:77-85. (Pubitemid 38899618)
23. Hall IP. Pharmacogenetics of asthma. Chest 2006;130:1873-1878
24. Israel E, Drazen JM, Liggett SB, Boushey HA, Cherniack RM, Chinchilli VM, Cooper DM, Fahy JV, Fish JE, Ford JG, Kraft M, Kunselman S, Lazarus SC, Lemanske RF, Martin RJ, McLean DE, Peters SP, Silverman EK, Sorkness CA, Szefler SJ, Weiss ST, Yandava CN. The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med 2000;162:75-80.
25. Israel E, Chinchilli VM, Ford JG, Boushey HA, Cherniack R, Craig TJ, Deykin A, Fagan JK, Fahy JV, Fish J, Kraft M, Kunselman SJ, Lazarus SC, Lemanske RF Jr, Liggett SB, Martin RJ, Mitra N, Peters SP, Silverman E, Sorkness CA, Szefler SJ, Wechsler ME, Weiss ST, Drazen JM; National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebocontrolled cross-over trial. Lancet 2004;364:1505-1512
26. Wechsler ME, Lehman E, Lazarus SC, Lemanske RF Jr, Boushey HA, Deykin A, Fahy JV, Sorkness CA, Chinchilli VM, Craig TJ, DiMango E, Kraft M, Leone F, Martin RJ, Peters SP, Szefler SJ, Liu W, Israel E; National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. beta-Adrenergic receptor polymorphisms and response to salmeterol. Am J Respir Crit Care Med 2006;173: 519-526
27. Palmer LJ, Silverman ES, Weiss ST, Drazen JM. Pharmacogenetics of asthma. Am J Respir Crit Care Med 2002;165:861-866
28. Sampson AP, Siddiqui S, Buchanan D, Howarth PH, Holgate ST, Holloway JW, Sayers I. Variant LTC(4) synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast. Thorax 2000;55 Suppl 2:S28-31.
29. Asano K, Shiomi T, Hasegawa N, Nakamura H, Kudo H, Matsuzaki T, Hakuno H, Fukunaga K, Suzuki Y, Kanazawa M, Yamaguchi K. Leukotriene C4 synthase gene A(-444)C polymorphism and clinical response to a CYS-LT(1) antagonist, pranlukast, in Japanese patients with moderate asthma. Pharmacogenetics 2002;12:565-570
30. Tamaoki J, Kondo M, Sakai N, Aoshiba K, Tagaya E, Nakata J, Isono K, Nagai A. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-blind randomised study. Lancet 2000;356:273-278 (Pubitemid 30459584)
31. Leung DY, Bloom JW. Update on glucocorticoid action and resistance. J Allergy Clin Immunol 2003;111:3-22.
32. Tantisira KG, Weiss ST. The pharmacogenetics of asthma: an update. Curr Opin Mol Ther 2005;7:209-217.
33. Szalai C, Ungvári I, Pelyhe L, Tölgyesi G, Falus A. Asthma from a pharmacogenomic point of view. Br J Pharmacol 2008;153:1602-1614
34. Tantisira KG, Hwang ES, Raby BA, Silverman ES, Lake SL, Richter BG, Peng SL, Drazen JM, Glimcher LH, Weiss ST. TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids. Proc Natl Acad Sci USA 2004;101:18099-18104